LM, W., QH, Y., L, Z., SY, L., PP, Z., X, Z., . . . TF, L. (2022). Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Rheumatology (Oxford, England), 61(9), 3704. https://doi.org/10.1093/rheumatology/keab928
Chicago Style (17th ed.) CitationLM, Wang, Yang QH, Zhang L, Liu SY, Zhang PP, Zhang X, Liu XJ, Han LS, and Li TF. "Intravenous Immunoglobulin for Interstitial Lung Diseases of Anti-melanoma Differentiation-associated Gene 5-positive Dermatomyositis." Rheumatology (Oxford, England) 61, no. 9 (2022): 3704. https://doi.org/10.1093/rheumatology/keab928.
MLA (9th ed.) CitationLM, Wang, et al. "Intravenous Immunoglobulin for Interstitial Lung Diseases of Anti-melanoma Differentiation-associated Gene 5-positive Dermatomyositis." Rheumatology (Oxford, England), vol. 61, no. 9, 2022, p. 3704, https://doi.org/10.1093/rheumatology/keab928.